Daan Gene Co., Ltd. (SHE:002030)
China flag China · Delayed Price · Currency is CNY
5.06
-0.01 (-0.20%)
Nov 17, 2026, 3:04 PM CST

Daan Gene Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Net Income
-742.97-744.38-925.17104.665,4123,618
Depreciation & Amortization
295.33295.33350.36357.14298.44192.02
Other Amortization
24.5324.5311.3710.8234.7820.45
Loss (Gain) From Sale of Assets
-5.48-5.48-9.13.041.15-0.11
Asset Writedown & Restructuring Costs
385.84385.8431.2880.89329.7915
Loss (Gain) From Sale of Investments
-54-54429.58-409.44-345.15-135.35
Provision & Write-off of Bad Debts
105.04105.04397.98142.36297.82130.73
Other Operating Activities
57.5128.4342.35169.99333.628.07
Change in Accounts Receivable
398.87398.87745.691,768-2,659-953.23
Change in Inventory
41.2741.2780.69-61.27-112.02-187.42
Change in Accounts Payable
-178.57-178.57-715.42-1,389649.84645.12
Operating Cash Flow
349.97319.49300.33780.114,1553,305
Operating Cash Flow Growth
40.31%6.38%-61.50%-81.22%25.73%31.42%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Capital Expenditures
-109.67-239-174.41-572.77-1,503-658.75
Sale of Property, Plant & Equipment
0.190.420.110.450.010.15
Cash Acquisitions
------0.04
Divestitures
--0--0.02
Investment in Securities
117.07-428.42-71.95442.98-505.95-746.99
Other Investing Activities
-9.6529.6828.8665.6548.7726.33
Investing Cash Flow
-2.06-637.32-217.39-63.69-1,960-1,379

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Short-Term Debt Issued
-123.01147.85318.52124.6284.55
Long-Term Debt Issued
-4.946.83550.0345
Total Debt Issued
114.63127.91194.65353.52174.64329.55
Short-Term Debt Repaid
--158.05-357.67-125.46-284.34-398.75
Long-Term Debt Repaid
--5.96-15.06-82.7-104.33-52.08
Total Debt Repaid
-114.97-164.01-372.73-208.16-388.67-450.83
Net Debt Issued (Repaid)
-0.34-36.1-178.08145.36-214.03-121.28
Issuance of Common Stock
1.46-----
Common Dividends Paid
-9.16-8.46-27.88-2,469-1,570-496.31
Other Financing Activities
-16.27----10.96-8.96
Financing Cash Flow
-24.3-44.55-205.96-2,323-1,795-626.55

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-2.34-1.331.112.2627.53-3.24
Net Cash Flow
321.27-363.71-121.9-1,605427.931,295

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Free Cash Flow
240.3180.49125.92207.342,6522,646
Free Cash Flow Growth
--36.08%-39.27%-92.18%0.24%23.08%
Free Cash Flow Margin
30.95%10.62%14.76%17.56%22.02%34.52%
Free Cash Flow Per Share
0.170.060.090.141.891.89
Levered Free Cash Flow
152.2129.51425.76432.931,4571,665
Unlevered Free Cash Flow
155.3132.13431.85439.211,4661,671

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Cash Income Tax Paid
15.8929.1650.76253.761,504754.19
Change in Working Capital
278.24278.24-37.15320.01-2,206-555.75